Do payers value rarity? An analysis of the relationship between disease rarity and orphan drug prices in Europe

• Main Authors: Goran Medic (Author), Daria Korchagina (Author), Katherine Eve Young (Author), Mondher Toumi (Author), Maarten Jacobus Postma (Author), Micheline Wille (Author), Michiel Hemels (Author)
• Format: Book
• Published: Taylor & Francis Group, 2017-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background and Objective: Orphan drugs have been a highlight of discussions due to their higher prices than non-orphan drugs. There is currently no European consensus on the method of value assessment for orphan drugs. This study assessed the relationship between the prevalence of rare diseases and...